| 2003 |
TBK1 and IKKε are essential kinases in the IRF3 signaling pathway downstream of TLR3 and viral dsRNA, coordinating activation of both IRF3 and NF-κB in the innate immune response. |
Genetic epistasis, kinase assays, loss-of-function studies in cell lines |
Nature immunology |
High |
12692549
|
| 2000 |
TBK1 (NAK) activates IKK through direct phosphorylation of IKKβ, thereby inducing IκB degradation and NF-κB activation downstream of PKCε and growth factors. |
In vitro kinase assay, co-immunoprecipitation, dominant-negative overexpression |
Nature |
High |
10783893
|
| 2012 |
STING functions as a scaffold protein to recruit both TBK1 and IRF3, specifying IRF3 phosphorylation by TBK1; the C-terminal tail of STING is necessary and sufficient to activate TBK1, and STING mutations that selectively disrupt IRF3 binding abrogate IRF3 phosphorylation without impairing TBK1 activation. |
In vitro reconstitution system, mutagenesis, co-immunoprecipitation |
Science signaling |
High |
22394562
|
| 2019 |
Cryo-EM structure of TBK1 in complex with cGAMP-bound full-length STING reveals the STING C-terminal tail inserts as a β-strand into a groove between the kinase domain of one TBK1 subunit and the scaffold/dimerization domain of the second; STING phosphorylation at Ser366 requires oligomerization of both STING and TBK1, validated by mutagenesis. |
Cryo-EM structure determination, mutational analysis |
Nature |
High |
30842653
|
| 2009 |
TBK1 is selectively essential in KRAS-mutant cancer cells; TBK1 activates NF-κB anti-apoptotic signals (via c-Rel and BCL-XL) that are required for survival of KRAS-dependent cancer cells, and TBK1 suppression induces apoptosis specifically in these cells. |
Systematic RNAi screen, loss-of-function apoptosis assays, mechanistic follow-up with NF-κB pathway analysis |
Nature |
High |
19847166
|
| 2018 |
TBK1 is an endogenous inhibitor of RIPK1 kinase; embryonic lethality of Tbk1-/- mice is rescued by inactivation of RIPK1, demonstrating TBK1 suppresses RIPK1-driven apoptosis during development. |
Genetic epistasis (double-mutant rescue), in vivo mouse models |
Cell |
High |
30146158
|
| 2018 |
TBK1 and IKKε phosphorylate RIPK1 within the TNFR1 signaling complex (recruited via LUBAC-dependent linear ubiquitin and NEMO/TANK/NAP1), preventing RIPK1-dependent cell death; NEMO recruits TBK1/IKKε via TANK and NAP1 adaptors. |
Co-immunoprecipitation, phosphorylation assays, in vivo TNF-shock model, genetic KO |
Nature cell biology |
High |
30420664
|
| 2019 |
TBK1 directly phosphorylates NDP52-associated ULK1 complex components; NDP52 recruits TBK1 to mitochondria/peroxisomes to focally activate the ULK1 complex, driving selective autophagosome biogenesis; this is independent of AMPK and mTOR. |
Chemically inducible dimerization (CID), CRISPR KO, live imaging |
Molecular cell |
High |
30853401
|
| 2018 |
TBK1 directly phosphorylates RAB7A at Ser72 upon mitochondrial depolarization in a PARKIN-dependent manner, promoting FLCN-FNIP1 association and ATG9A vesicle recruitment to support mitophagy. |
Global quantitative proteomics, in vitro kinase assay, interaction proteomics with phosphomimetic/non-phosphorylatable mutants |
Science advances |
High |
30627666
|
| 2019 |
TBK1 phosphorylates Syntaxin 17 (Stx17) at Ser202, translocating it from the Golgi to ATG13+FIP200+ pre-autophagosomal structures to control autophagy initiation; TBK1 or Stx17 knockout blocks ATG13 and FIP200 puncta formation. |
Phosphorylation site mapping, KO cell lines, live imaging, co-immunoprecipitation |
Developmental cell |
High |
30827897
|
| 2018 |
TBK1 directly inhibits AMPK to repress cellular respiration and promote energy storage in adipocytes; conversely, AMPK activates TBK1 through ULK1-mediated phosphorylation under catabolic conditions. TBK1 also suppresses inflammation by phosphorylating and inducing degradation of NIK, attenuating NF-κB activity. |
Adipocyte-specific TBK1 KO mice, in vitro kinase assays, co-immunoprecipitation |
Cell |
High |
29425491
|
| 2015 |
Loss-of-function mutations in TBK1 cause familial ALS; CCD2 domain mutations specifically disrupt TBK1 interaction with the adaptor protein optineurin, linking TBK1-optineurin interaction to ALS pathogenesis. |
Exome sequencing, in vitro co-immunoprecipitation, linkage analysis |
Nature neuroscience |
High |
25803835
|
| 2017 |
TRIM23 undergoes K27-linked auto-ubiquitination of its ARF domain, which activates its GTP hydrolysis and facilitates TBK1 dimerization; activated TBK1 then phosphorylates p62 to promote selective autophagy. |
RNAi screen, ubiquitination assays, mechanistic mutagenesis, co-immunoprecipitation |
Nature microbiology |
High |
28871090
|
| 2017 |
MAVS activates TBK1 and IKKε through TRAFs; TRAFs interact directly via their coiled-coil domain with the SDD domain of TBK1/IKKε, and TRAF E3 ligase activity synthesizes ubiquitin chains that activate NEMO and subsequently IKKα/β, which then phosphorylate TBK1/IKKε. |
Knockout cell lines, co-immunoprecipitation, epistasis analysis |
PLoS pathogens |
High |
29125880
|
| 2015 |
TBK1 controls AKT-mTORC1 signaling in T cells by promoting AKT ubiquitination and degradation; T cell-specific TBK1 ablation causes enhanced T-cell activation and impaired effector T-cell egress from draining lymph nodes. |
T cell-conditional TBK1 KO mice, AKT ubiquitination assays, EAE model |
Nature communications |
High |
25606824
|
| 2019 |
TBK1 is activated by growth factor signaling through a TBKBP1-CARD10-PKCθ axis; PKCθ phosphorylates TBK1 at Ser716, specifically enabling growth-factor-driven (not innate immune) TBK1 activation, which mediates mTORC1 activation and oncogenesis. |
Co-immunoprecipitation, phosphorylation site mutagenesis, conditional KO mice, lung cancer model |
Nature cell biology |
High |
31792381
|
| 2017 |
TBK1 phosphorylates the exocyst subunit Exo84 upon RalA activation by insulin, reducing Exo84's affinity for RalA and enabling exocyst complex release to support GLUT4 vesicle fusion at the plasma membrane. |
In vitro kinase assay, KD/KO in adipocytes, phosphomimetic and non-phosphorylatable mutants, GLUT4 translocation assay |
Science signaling |
High |
28325821
|
| 2020 |
TBK1 and IKKε act redundantly to mediate STING-induced NF-κB responses; TBK1 alone is dispensable for NF-κB activation but highly dependent upon for IRF3 activation downstream of cGAS-STING. |
Genetic KO (TBK1 and IKKε single and double KO), pharmacological inhibition, in vivo mouse studies |
Cell reports |
High |
32268090
|
| 2021 |
TBK1 recruitment to STING via the STING C-terminal tail (not merely IRF3 binding) mediates autoinflammatory arthritis and NF-κB activation; STING S365A mutation (abrogating IRF3 binding) retains TBK1 recruitment and NF-κB activation causing arthritis, while STING L373A or C-terminal truncation disrupting TBK1 binding rescues DNase II-/- phenotypes. |
STING knock-in point mutant mice, in vivo disease model, cytokine neutralization |
The Journal of experimental medicine |
High |
34901991
|
| 2020 |
TBK1 directly phosphorylates DRP1/DNM1L upon RLR-MAVS signaling activation, preventing DRP1 high-order oligomerization and mitochondrial fragmentation; this TBK1-DRP1 axis is essential for assembly of large MAVS aggregates and antiviral immunity. |
In vitro kinase assay, knock-in mouse models, dominant-negative mutant analysis, biochemical fractionation |
Molecular cell |
High |
33171123
|
| 2021 |
TBK1 phosphorylates METTL3 at Ser67 upon viral infection; phospho-METTL3 associates with the translational complex to enhance protein translation of antiviral factors, and TBK1-mediated METTL3 activation stabilizes IRF3 mRNA via m6A modification. |
Phosphorylation site mapping, co-immunoprecipitation, KO mouse models |
Cell reports |
High |
35172162
|
| 2021 |
PRMT1 directly interacts with TBK1 and catalyzes asymmetric dimethylation of TBK1 at R54, R134, and R228; this modification enhances TBK1 oligomerization after viral infection, promoting TBK1 phosphorylation and type I interferon production. |
In vitro methylation assay, co-immunoprecipitation, myeloid-specific KO mice, site-directed mutagenesis |
Cell reports |
High |
34551290
|
| 2019 |
TBK1 activates TBK1 via a positive feedback mechanism at mitophagy contact sites; optineurin (OPTN) provides the platform by simultaneously binding ubiquitin and pre-autophagosomal structures, assembling the OPTN-TBK1 complex at mitochondria-autophagosome contact sites where hetero-autophosphorylation of TBK1 is initiated. |
Live imaging, CRISPR KO, engineered monobody inhibitors, biochemical fractionation |
The EMBO journal |
High |
38287189
|
| 2020 |
TBC1D9 activates TBK1 during xenophagy and mitophagy in a Ca2+-dependent manner; TBC1D9's ubiquitin-binding region and Ca2+-binding motif mediate its association with ubiquitinated bacteria/mitochondria, and Ca2+ chelation impairs TBC1D9-ubiquitin interactions and blocks TBK1 activation. |
KO cell lines, co-immunoprecipitation, Ca2+ chelation experiments, xenophagy/mitophagy assays |
Nature communications |
High |
32034138
|
| 2021 |
NEDD4 catalyzes K27-linked polyubiquitination of TBK1 at K344, which serves as a recognition signal for NDP52-mediated selective autophagic degradation of TBK1, thereby limiting type I IFN signaling. |
Ubiquitination assays with K344 mutagenesis, co-immunoprecipitation, selective autophagy assays |
Cell death and differentiation |
High |
34257412
|
| 2017 |
The USP1-UAF1 deubiquitinase complex binds TBK1, removes K48-linked polyubiquitination, and stabilizes TBK1 protein levels, enhancing IRF3 activation and IFN-β production upon viral infection. |
Co-immunoprecipitation, ubiquitination assays, small molecule inhibitor (ML323), in vitro and in vivo viral infection |
The Journal of experimental medicine |
High |
29138248
|
| 2020 |
TBK1 directly phosphorylates mTOR at S2159 within mTORC2, increasing mTORC2 intrinsic catalytic activity and downstream Akt phosphorylation; TBK1 co-immunoprecipitates with mTORC2. |
In vitro kinase assays, co-immunoprecipitation, Mtor S2159A knock-in mice, MEFs lacking TBK1 |
The Journal of biological chemistry |
High |
34245780
|
| 2019 |
The receptor tyrosine kinase Axl induces TBK1 activity in a Ras-RalB-dependent manner in pancreatic cancer cells, driving epithelial-mesenchymal transition and metastasis. |
Loss-of-function studies (genetic and pharmacological), in vivo tumor models, pathway analysis |
JCI insight |
Medium |
30938713
|
| 2021 |
TBK1 phosphorylates mutant huntingtin (mHTT) at S13 in vitro and in cells/in vivo, increasing mHTT exon1 phosphorylation, reducing its aggregation, and enhancing autophagic clearance to protect against toxicity in HD models. |
In vitro kinase assay coupled to MS, cell and primary neuron models, C. elegans experiments, site mapping |
The EMBO journal |
High |
32757223
|
| 2019 |
TBK1 activates MVB12b by phosphorylation; this is essential for the sorting of bacterial DNA into extracellular vesicles enabling paracrine cGAS-STING signaling to bystander cells during Listeria infection. |
Phosphorylation assays, siRNA knockdown, extracellular vesicle isolation, bystander cell stimulation assays |
Nature microbiology |
Medium |
30804548
|
| 2021 |
TBK1 interacts with NLRP3 and acts as an OFF switch limiting NLRP3 inflammasome activation; combined TBK1 and IKKε deletion (but not single KO) increases NLRP3 activation, and TBK1 controls NLRP3 at phospho-sites distinct from Ser3. |
Double KO (TBK1 and IKKε), pharmacological inhibition, mutagenesis, co-immunoprecipitation, in vivo peritonitis model |
Proceedings of the National Academy of Sciences of the United States of America |
High |
34518217
|
| 2021 |
TBK1 is required for B cell germinal center formation by regulating the balance of IRF4/BCL6 expression through limiting CD40 and BCR activation via noncanonical NF-κB and AKT-T308 signaling. |
B cell-conditional TBK1 KO mice, immunization and malaria infection models, signaling assays |
The Journal of experimental medicine |
High |
34910106
|
| 2022 |
TBK1 phosphorylates STING C-terminal tail at Ser366 and the phosphorylation requires TGN localization; after STING stimulation, TBK1 specifically associates with the trans-Golgi network (TGN), not other Golgi compartments, establishing TGN as the activation platform. |
Live-cell fluorescence imaging with stable fluorescent protein-tagged STING and TBK1, STING variant analysis |
Cell structure and function |
Medium |
35125375
|
| 2019 |
NDP52 (CALCOCO2) forms a trimer with FIP200 (ULK complex) and SINTBAD/NAP1 (TBK1 complex) to recruit both kinase complexes to cargo, initiating selective autophagy at cargo-determined locations. |
Selective autophagy reconstitution, co-immunoprecipitation, CRISPR KO |
Autophagy |
Medium |
31258038
|
| 2018 |
Loss of TBK1 kinase function protects against diet-induced metabolic dysfunction partly through loss of an inhibitory interaction between TBK1 and the insulin receptor. |
Global Tbk1 kinase-dead mutant mice, high-fat diet metabolic phenotyping, co-immunoprecipitation |
Molecular metabolism |
Medium |
29935921
|
| 2024 |
TBK1 adaptors NAP1 and SINTBAD compete with OPTN for TBK1 binding, restricting mitophagy initiation, while simultaneously promoting NDP52-driven mitophagy by recruiting TBK1 to NDP52 and stabilizing NDP52-FIP200 interaction. |
Co-immunoprecipitation, CRISPR KO, selective autophagy assays, live imaging |
Nature structural & molecular biology |
High |
38918639
|
| 2021 |
SIRT5 desuccinylates TBK1; succinylation at K38, K154, and K692 inhibits TBK1 binding to IRF3 and TRAF2 and suppresses inflammatory signaling; the K154/692R succinylation-resistant TBK1 mutant restores inflammatory cytokine production in macrophages. |
Succinylation site mutagenesis, adoptive macrophage transfer, in vivo sepsis model, co-immunoprecipitation |
Cell reports |
High |
39673708
|
| 2025 |
SIRT5 desuccinylates TBK1 at lysine 137, leading to TBK1 dephosphorylation and suppression of downstream inflammatory pathways; SIRT5 deficiency increases TBK1 succinylation and hastens muscle cell senescence. |
SIRT5 KO in human myotubes, lentiviral gene therapy in mice, site-directed mutagenesis, co-immunoprecipitation |
Nature metabolism |
High |
40087407
|
| 2023 |
PTK2B directly phosphorylates TBK1 at Tyr591, increasing TBK1 oligomerization and activation; PTK2B also promotes STING oligomerization in a kinase-independent manner; Ptk2b-deficient mice show increased susceptibility to viral infection. |
In vitro phosphorylation assay, co-immunoprecipitation, CRISPR KO, Ptk2b-deficient mice |
Nature communications |
High |
37989995
|
| 2019 |
PINK1 and Parkin-mediated activation of TBK1 at mitochondria during mitophagy sequesters TBK1 from centrosomes, blocking its physiological role there and inhibiting mitosis; PINK1 and Parkin genetically interact with cell cycle regulators. |
Genetic interaction analysis, live imaging of TBK1 at mitochondria and centrosomes, PINK1/Parkin KO |
Cell reports |
Medium |
31577952
|
| 2024 |
FIP200 controls TBK1 activation threshold at SQSTM1/p62-positive condensates; TBK1 is recruited to these condensates via TAX1BP1, phosphorylates SQSTM1/p62 at Ser403; loss of FIP200 or its inability to bind TAX1BP1 strongly increases TBK1 activation at condensates. |
Co-immunoprecipitation, KO cell lines, phosphorylation assays |
Scientific reports |
Medium |
34226595
|
| 2022 |
Vimentin interacts with TBK1 and IKKε, disrupting TBK1-IRF3 and IKKε-IRF3 interactions, thereby inhibiting IRF3 phosphorylation and nuclear translocation and suppressing type I IFN production upon viral infection. |
Co-immunoprecipitation, overexpression and KO of vimentin, IFN reporter assays, vimentin KO mice |
Cell reports |
Medium |
36223739
|
| 2022 |
TBK1 regulates YAP/TAZ activity in fibroblasts; TBK1 knockdown or inhibition reduces YAP/TAZ total and nuclear levels, suppressing fibrogenic activation; this is independent of LATS1/2 and IRF3 but dependent on proteasomal machinery. |
siRNA knockdown, pharmacological inhibition (MRT-68601), western blot, YAP/TAZ localization assays |
American journal of physiology. Lung cellular and molecular physiology |
Medium |
32159970
|
| 2024 |
USP38 interacts with TBK1 and removes K48-linked polyubiquitination, stabilizing phospho-TBK1 and promoting its downstream signaling in pathological cardiac remodeling. |
Cardiac-specific USP38 KO and OE mice, co-immunoprecipitation, ubiquitination assays, TBK1 OE rescue |
International journal of biological sciences |
Medium |
38481817
|
| 2018 |
ALS-associated TBK1 missense mutations (e.g., G217R) abolish TBK1 ability to phosphorylate IRF3 and optineurin, block binding to optineurin, and reduce homodimerization; this establishes loss of kinase function as a common mechanism for both missense and truncation ALS mutations. |
In vitro kinase assays, co-immunoprecipitation, patient-derived lymphoblastoid cell lines |
Neurobiology of aging |
High |
30033073
|
| 2021 |
ALS-linked TBK1 mutations that abolish dimerization or kinase activity are individually insufficient to fully block mitophagy; mutations reducing both dimerization and kinase activity are more disruptive; TBK1 recruitment and OPTN phosphorylation at S177 are both necessary for autophagosomal engulfment of damaged mitochondria. |
Live imaging in cell lines and primary neurons, CRISPR KO, mitophagy flux assays |
Proceedings of the National Academy of Sciences of the United States of America |
High |
34099552
|